Trials / Unknown
UnknownNCT00188994
Insulin Cardioplegia for Poor Left Ventricular Function
Insulin Cardioplegia Trial for Poor Left Ventricular Function
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 800 (planned)
- Sponsor
- University Health Network, Toronto · Academic / Other
- Sex
- All
- Age
- 0 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this investigation is to develop a means to improve the recovery of cardiac metabolism and ventricular function following coronary artery bypass surgery (CABG) in patients with poor preoperative ventricular function (e.g. ejection fraction \<40%).
Detailed description
Hypothesis Insulin added to blood cardioplegia will improve the results of Coronary Artery Bypass Graft by reducing the incidence of low output syndrome (i.e., the requirement for inotropic or balloon pump assistance) in patients with a preoperative ejection fraction \<40%.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Insulin Cardioplegia |
Timeline
- Start date
- 1999-08-01
- First posted
- 2005-09-16
- Last updated
- 2005-12-29
Locations
1 site across 1 country: Canada
Source: ClinicalTrials.gov record NCT00188994. Inclusion in this directory is not an endorsement.